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Background: The precise role of an autoimmune process in the etiology of idiopathic dilated cardiomyopathy (iDCM) is unclear. We sought to 
assess autoimmune T-cell responses to cardiac troponin I (cTnI) in iDCM using enzyme-linked immunospot assay (ELISPOT) and to compare with 
extended cellular proliferative response measured by flow cytometry and the presence of autoantibodies (AAbs) to cTnI.
Methods: ELISPOT assay was used to determine the ex vivo interferon-g (IFNg) and interleukin-10 (IL-10) production by peripheral blood 
mononuclear cells (PBMCs) in response to cTnI in iDCM subjects and controls. Cellular response was identified by staining PBMCs with CFSE dye and 
culturing for 7 days with 10 mg/mL of cTnI. AAbs against cTnI were detected by ELISA.
Results: 46 subjects with iDCM (mean age 52±12 years, 46% male, LVEF 23±7%) and 30 controls (mean age 47±14years, 63% male) were 
included. The IFNg response to cTnI correlated with the IL-10 response to cTnI, r 0.287, p=0.002. Subjects with iDCM showed significantly higher IL-
10 responses to cTnI compared with control (Figure 1). However, neither IFNg or IL-10 responses to cTnI correlated with the presence of AAbs to cTnI 
(6/46, 13%) or to a positive cellular proliferative response to cTnI (9/46, 19%).
Conclusions: In subjects with iDCM, increased autoimmune T cell response to cTnI was detected in peripheral blood regardless of the presence of 
AAbs against cTnI. This illustrates the complexity of autoimmune T-cell response to pathogenesis of iDCM.
